Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
2,045 articles
📰
Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
- Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4
DAEJEON, South Korea, March 25,...
📰
Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
- Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4
DAEJEON, South Korea, March 25,...
📰
Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
- Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 DAEJEON, South Korea, March 25,...
Mark Zuckerberg's Meta Platforms $9 Trillion AI Moonshot Could Unlock Massive Executive Paydays If The Bet Pays Off
Meta Platforms, Inc. (NASDAQ:META) has introduced a new stock option program that could deliver massive payouts to top executives if the company...
EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch
Co-Diagnostics Inc. (NASDAQ:CODX) on Wednesday announced that it has commenced shipments of PCR Pro instruments, Co-Dx PCR MTB test kits for...
Google Accelerates Quantum Timeline: New Dual-Track Strategy Aims For 2030 Commercial Breakthrough
Alphabet Inc (NASDAQ:GOOGL) (NASDAQ:GOOG) Google is ramping up its quantum computing efforts while analysts point to strong long-term potential for...
ARM Stock's Momentum Score Leaps Fueled By In-House AGI Chip Ambitions
Arm Holdings Plc (NASDAQ:ARM), a crucial chip architecture partner for tech giants Nvidia Corp. (NASDAQ:NVDA) and Apple Inc. (NASDAQ:AAPL), is...
Arm's Big AI Chip Move With Meta Sends Stock Soaring
Arm Holdings Plc (NASDAQ:ARM) shares are rising in Wednesday's premarket session.
The company announced a major expansion into production...
Meta CTO Andrew Bosworth To Lead Massive 'AI For Work' Takeover Across 78,000 Staff
Meta Platforms, Inc (NASDAQ:META) is accelerating its AI push internally while analysts see the strategy supporting long-term growth.
CTO Takes Lead...
BAE Systems and U.S. Department of War sign agreement to quadruple THAAD seeker production
FALLS CHURCH, Va. and NASHUA, N.H., March 25, 2026 /PRNewswire/ -- BAE Systems (LON: BA) has signed a landmark seven-year framework agreement with...
Lockheed Martin Answers the Nation's Call and Quadruples Precision Strike Missile Production
New agreement between Lockheed Martin and the Department of War ensures joint forces have the military advantage they need DALLAS, March 25, 2026...
HONEYWELL AEROSPACE, DEPARTMENT OF WAR SIGN GROUNDBREAKING AGREEMENT TO ACCELERATE PRODUCTION OF DEFENSE TECHNOLOGIES
Honeywell to commit $500 million for production capacity upgrades PHOENIX, March 25, 2026 /PRNewswire/ -- Honeywell (NASDAQ: HON) today announced it...
📰
Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development
Treatment with 60 mg of BEAM-302 Led to Mean Steady-state Total AAT Level of 16.1 µM and All Patients Consistently and Durably Above the 11 µM...
Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers
VANCOUVER, British Columbia, March 25, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0)...
📰
Picard Medical Reports Full Year 2025 Financial Results
Revenue Growth and Continued Adoption of SynCardia Total Artificial Heart Revenue Growth and Continued Adoption of SynCardia Total Artificial Heart
Guidehouse Secures All Six Lots on UK Government's £18B TS4 Framework
Placement across all lots reinforces Guidehouse's ability to deliver integrated strategy, design, and technology services LONDON, March 25, 2026...
📰
Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development
Treatment with 60 mg of BEAM-302 Led to Mean Steady-state Total AAT Level of 16.1 µM and All Patients Consistently and Durably Above the 11 µM...
📰
C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma
Novel Combination Regimen Positions Cemsidomide for Use in Earlier Lines of Therapy Novel Combination Regimen Positions Cemsidomide for Use in...
📰
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
Positive topline data from Phase 2 HORIZON trial of MZE829 demonstrating first clinical proof-of-concept in patients with broad AMKD to support...
📰
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
Positive topline data from Phase 2 HORIZON trial of MZE829 demonstrating first clinical proof-of-concept in patients with broad AMKD to support...
📰
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
Terns' lead candidate TERN-701 is an investigational oral allosteric BCR::ABL1 tyrosine kinase inhibitor currently in Phase 1/2 development for...
📰
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
Terns' lead candidate TERN-701 is an investigational oral allosteric BCR::ABL1 tyrosine kinase inhibitor currently in Phase 1/2 development for...
📰
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
Terns’ lead candidate TERN-701 is an investigational oral allosteric BCR::ABL1 tyrosine kinase inhibitor currently in Phase 1/2 development for...
Merck Nears $6 Billion Deal To Buy Terns Pharma: Report
Merck & Co. Inc. (NYSE:MRK) is nearing an all-cash deal to acquire Terns Pharmaceuticals, Inc. (NASDAQ:TERN) for roughly $6 billion, aiming to...
Merck Nears $6 Billion Deal To Buy Terns Pharma: Report
Merck & Co. Inc. (NYSE:MRK) is nearing an all-cash deal to acquire Terns Pharmaceuticals, Inc. (NASDAQ:TERN) for roughly $6 billion, aiming to...
Merck Nears $6 Billion Deal To Buy Terns Pharma: Report
Merck & Co. Inc. (NYSE:MRK) is nearing an all-cash deal to acquire Terns Pharmaceuticals, Inc. (NASDAQ:TERN) for roughly $6 billion, aiming to...
📰
3 Top-Ranked Healthcare Mutual Funds Set for Solid Growth
We share with you three top-ranked healthcare mutual funds. Each has a Zacks Mutual Fund Rank #1 (Strong Buy).
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Diversified Trust Co.
Diversified Trust Co. lifted its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 223.5% during the fourth quarter, according...
Dynamic Advisor Solutions LLC Buys 3,691 Shares of Astrazeneca Plc $AZN
Dynamic Advisor Solutions LLC grew its stake in Astrazeneca Plc (NYSE:AZN – Free Report) by 25.4% during the fourth quarter, according to the...
Dynamic Advisor Solutions LLC Buys 3,691 Shares of Astrazeneca Plc $AZN
Dynamic Advisor Solutions LLC grew its stake in Astrazeneca Plc (NYSE:AZN – Free Report) by 25.4% during the fourth quarter, according to the...
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Diversified Trust Co.
Diversified Trust Co. lifted its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 223.5% during the fourth quarter, according...
New Strong Buy Stocks for March 25th
EQT, BCBP, FIX, PAAS and ADMA have been added to the Zacks Rank #1 (Strong Buy) List on March 25, 2026.
Stock Market Today: S&P 500, Dow Futures Surge Despite Iran Saying Trump Admin Is 'Negotiating With Itself'—Robinhood, Circle, Arm Holdings In Focus
U.S. stock futures rose on Wednesday following Tuesday’s declines. Futures of the major benchmark indices were higher.
President Donald...
Braze Stock Jumps Over 23% In Pre-Market Session—Here's Why
Braze Inc. (NASDAQ:BRZE) climbed 23.36% to $22.23 in pre-market trading on Wednesday after the company released its fiscal fourth-quarter 2026...
Diversified Trust Co. Purchases 6,742 Shares of Insulet Corporation $PODD
Diversified Trust Co. grew its position in Insulet Corporation (NASDAQ:PODD – Free Report) by 495.7% in the 4th quarter, according to its most...
Congress Asset Management Co. Buys 10,721 Shares of Insulet Corporation $PODD
Congress Asset Management Co. raised its stake in Insulet Corporation (NASDAQ:PODD – Free Report) by 11.9% in the fourth quarter, according to...
Diversified Trust Co. Raises Position in Eli Lilly and Company $LLY
Diversified Trust Co. grew its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 20.6% in the 4th quarter, according to its most...
Diversified Trust Co. Raises Position in Eli Lilly and Company $LLY
Diversified Trust Co. grew its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 20.6% in the 4th quarter, according to its most...
Astrazeneca Plc $AZN Shares Acquired by Brucke Financial Inc.
Brucke Financial Inc. increased its stake in shares of Astrazeneca Plc (NYSE:AZN – Free Report) by 25.0% in the fourth quarter, according to...
Astrazeneca Plc $AZN Shares Acquired by Brucke Financial Inc.
Brucke Financial Inc. increased its stake in shares of Astrazeneca Plc (NYSE:AZN – Free Report) by 25.0% in the fourth quarter, according to...
Why Blaize Holdings Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
Shares of Blaize Holdings Inc (NASDAQ:BZAI) rose sharply in pre-market trading after the company reported better-than-expected quarterly financial...
Why Blaize Holdings Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
Shares of Blaize Holdings Inc (NASDAQ:BZAI) rose sharply in pre-market trading after the company reported better-than-expected quarterly financial...